BNTX

#536
BioNTech SE American Depositary Share
98.41 USD
+1.77%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
98.41
98.41
Jahresspanne
79.52
123.98
Tagesänderung
+1.77%
Monatliche Änderung
+6.97%
6 month change
-3.97%
Jahresänderung
-3.79%
Vorheriger Schlusskurs
96.70
Eröffnung
98.41
Bid
Ask
Tief
98.41
High
98.41
Volumen
118
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert 202020212022202320242025 TTM

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Nachrichten